Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World s Most Innovative and Comprehensive Orthopaedics Business
|
|
- Jeffery Beasley
- 5 years ago
- Views:
Transcription
1 Filed by Johnson & Johnson Pursuant to Rule 425 under the Securities Act of 1933 Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World s Most Innovative and Comprehensive Orthopaedics Business
2 Transaction Overview Johnson & Johnson has entered into a definitive merger agreement to acquire Synthes Price per Synthes share: based on CHF per share; transaction valued at $21.3 Bn Subject to certain conditions, shares will be exchanged for CHF in cash and CHF in J&J common stock Net acquisition cost of $19.3 Bn Anticipated closing: first half of 2012 Subject to regulatory approvals
3 A Compelling Combination: DePuy & Synthes Opportunity to help millions of patients around the world Future Growth Formula: Increased breadth and depth of technology worldwide DePuy offers a strong portfolio in joint replacement and sports medicine Synthes is a leader in trauma, cranio-maxillofacial, and power tools Both companies provide complementary portfolios in spine Shared capabilities and services Product development and robust pipelines Potential for convergence across Johnson & Johnson Global reach in developed and particularly in emerging markets Deep expertise and commitment to professional education Shared cultural beliefs Both companies share similar values Work relentlessly to meet the needs of health care professionals and health systems
4 Synthes: Business Overview Well recognized for innovation and business leadership Trauma, spine, cranio-maxillofacial and power tools 2011 key priorities Continued growth through new products 70% of 2010 sales growth in new products Target under-penetrated markets Emerging markets: investment to drive continued growth Productivity improvement initiatives
5 Synthes Impressive Operating Model Financial Strength: Revenue $3.7 Billion; Sales CAGR ( 01-10) 15% Gross Profit $3.0 Billion; 83% to sales Operating Income $1.3 Billion; 35% to sales Net Income $0.9 Billion; 24% to sales Infrastructure: Employees: > 11,000 Over 40 subsidiaries and 50 distributors across 4 regions NA accounts for 60% of global sales AO Foundation Production facilities in the United States, Austria, China, Germany and Switzerland
6 SOURCE: Wall Street research and Synthes investor presentation Complementary Strengths: Synthes Position in Trauma Disease areas Market size/ Growth 1 Fractures Deformities Limb Tumors Long limb stability $4.7 Billion / 7% CAGR ( 10-18) Major products Plates and screw systems Intramedullary nailing systems External fixation Bone void fillers Consistent growth Customer loyalty Stable Pricing 1 Based on 2010 figures
7 SOURCE: Wall Street research and Samson investor presentation Complementary Strengths: Synthes Position in CMF Disease areas Market size/ Growth 1 Facial trauma/ reconstruction Head and neck tumors Craniofacial surgery $0.7 Billion / 7% CAGR ( 10-18) Major products Plates and screw systems Rapid resorbable fixation Orthodontic bone anchor Patient-specific implants Sternal closure (market expansion) Growing volume (e.g., tumors) New technologies/techniques Stable pricing 1 Based on 2010 figures
8 Complementary Strengths: DePuy s Position in Knee Replacement SOURCE: DePuy internal estimates Disease areas Osteoarthritis Major products Sigma High Performance Platform Sigma High Performance Partial Knee Market size/ Growth 1 $7.3 Billion / 5.0% CAGR ( 10-18%) Most commonly performed joint replacement Favorable demographics Continued demand for improvements in technology 1 Based on 2010 figures
9 SOURCE: DePuy internal estimates Complementary Strengths: DePuy s Position in Hip Replacement Major products Disease areas Market size/ Growth 1 Osteoarthritis Osteoporotic fracture $6.5 Billion / 4.5% CAGR ( 10-18%) AltrX Altralinked Polyethylene Pinnacle Acetabular Cup System Ceramax Ceramic-on-Ceramic Total Hip System Favorable demographics Drive toward minimally invasive procedures Continued demand for improvements in technologies 1 Based on 2010 figures
10 Significant Shareholder Value 2011 Guidance: No impact to previously communicated guidance; excluding the impact of special items After tax charges related to the cost of the transaction ($500-$600 MM); to be included in special items And Beyond: 2012 will have a modestly dilutive impact: (1-2%) of earnings per share, excluding special items Special items considered on an after tax basis are amortization of intangibles and inventory step up, restructuring costs, and other costs to execute the transaction 2012 current estimates of $1-$1.2 billion Integration plans will be evaluating cost synergy opportunities Strategically important for enhancing our leadership position in healthcare
11 The Future Growth Formula Creating the world's most comprehensive and innovative orthopaedics business Enhanced portfolio of products in key orthopaedic categories Enhanced presence in major developed and emerging markets Breadth of technologies for new product development Dedication to professional development and service Benefits millions of patients around the world
12 Additional Information and Where to Find It Johnson & Johnson will file with the SEC a registration statement on Form S-4, in which a proxy statement will be included as a prospectus, and other documents in connection with the proposed acquisition of Synthes. The proxy statement/prospectus will be sent to the stockholders of Synthes. Before making any decision with respect to the proposed transaction, stockholders of Synthes are urged to read the proxy statement/prospectus and other relevant materials because these materials will contain important information about the proposed transaction. The registration statement and proxy statement/prospectus and other documents which will be filed by Johnson & Johnson with the SEC will be available free of charge at the SEC s website, or by directing a request to Johnson & Johnson, One Johnson & Johnson Plaza, New Brunswick, NJ 08933, Attention: Investor Relations; or by directing a request to Synthes, Inc., c/o Synthes Gmbh, Glutz-Blotzheim-Strasse 3, 4500 Solothurn, Switzerland, Attention: Investor Relations. Certain executive officers and directors of Synthes have interests in the proposed transaction that may differ from the interests of stockholders generally, including benefits conferred under retention, severance and change in control arrangements and continuation of director and officer insurance and indemnification. This communication shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of such securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to appropriate registration or qualification under the securities laws of such jurisdiction. (This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson and Synthes, Inc. Risks and uncertainties include, but are not limited to, the satisfaction of closing conditions for the acquisition, including receipt of regulatory approvals for the transaction, receipt of approval by the shareholders of Synthes for the transaction, and the possibility that the transaction will not be completed, or if completed, will not be completed on a timely basis; general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; trends toward health care cost containment; and increased scrutiny of the healthcare industry by government agencies. In addition, if and when the transaction is consummated, there will be risks and uncertainties related to Johnson & Johnson s ability to successfully integrate the products and employees of Johnson & Johnson and Synthes, as well as the ability to ensure continued performance or market growth of Synthes products. A further list and description of these risks, uncertainties and other factors and the general risks associated with the respective businesses of Johnson & Johnson and Synthes can be found in Exhibit 99 of Johnson & Johnson s Annual Report on Form 10-K for the fiscal year ended January 2, 2011, and Synthes Annual Report Copies of these filings, as well as subsequent filings, are available online at or on request from Johnson & Johnson or Synthes. Neither Johnson & Johnson nor Synthes undertakes to update any forward-looking statements as a result of new information or future events or developments.)
13
Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014
Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014 David Dvorak President and Chief Executive Officer Jim Crines EVP, Finance, and Chief Financial Officer Cautionary Statement
More informationZimmer Biomet Reports Second Quarter 2016 Financial Results
July 28, 2016 Zimmer Biomet Reports Second Quarter 2016 Financial Results -- Net Sales of $1.934 billion represent an increase of 65.6% over the prior year period, and an increase of 4.5% on an adjusted
More informationBIOMET ANNOUNCES FIRST QUARTER OF FISCAL YEAR 2015 FINANCIAL RESULTS
BIOMET ANNOUNCES FIRST QUARTER OF FISCAL YEAR 2015 FINANCIAL RESULTS WARSAW, Ind., October 9, 2014 Biomet, Inc. ( the Company ) announced today financial results for its first quarter ended. First Quarter
More informationBIOMET ANNOUNCES SECOND QUARTER OF FISCAL YEAR 2015 FINANCIAL RESULTS
BIOMET ANNOUNCES SECOND QUARTER OF FISCAL YEAR 2015 FINANCIAL RESULTS WARSAW, Ind., January 6, 2015 Biomet, Inc. ( the Company ) announced today financial results for its second quarter ended. Second Quarter
More informationBIOMET ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2014 PRELIMINARY FINANCIAL RESULTS
BIOMET ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2014 PRELIMINARY FINANCIAL RESULTS WARSAW, Ind., July 9, 2014 Biomet, Inc. ( the Company ) announced today preliminary financial results for its fourth quarter
More informationBIOMET ANNOUNCES FIRST QUARTER OF FISCAL YEAR 2013 FINANCIAL RESULTS
BIOMET ANNOUNCES FIRST QUARTER OF FISCAL YEAR 2013 FINANCIAL RESULTS WARSAW, Ind., October 10, 2012 Biomet, Inc. announced today financial results for its first fiscal quarter ended August 31, 2012. Initial
More informationBIOMET ANNOUNCES SECOND QUARTER OF FISCAL YEAR 2013 FINANCIAL RESULTS
BIOMET ANNOUNCES SECOND QUARTER OF FISCAL YEAR 2013 FINANCIAL RESULTS WARSAW, Ind., January 8, 2013 Biomet, Inc. announced today financial results for its second fiscal quarter ended November 30, 2012.
More informationZimmer Biomet Reports Second Quarter 2017 Financial Results
Zimmer Biomet Reports Second Quarter 2017 Financial Results Jul 27, 2017 - Net sales of $1.954 billion for the second quarter represent an increase of 1.1% over the prior year period, and an increase of
More informationJP Morgan 2014 Healthcare Conference
JP Morgan 2014 Healthcare Conference January 14, 2014 David Dvorak President and CEO Focus on Musculoskeletal Healthcare Leadership Safe Harbor Statement Statements made during this presentation that are
More informationZimmer Biomet Holdings, Inc. 1 st Quarter 2018 Earnings Call Presentation. April 26, 2018
Zimmer Biomet Holdings, Inc. 1 st Quarter 2018 Earnings Call Presentation April 26, 2018 Cautionary Note on Forward-Looking Statements and Non- GAAP Financial Measures Cautionary Note on Forward-Looking
More informationProject Mountain Investor Presentation. AECOM Investor Presentation. World Trade Center Manhattan, New York, U.S.A.
Project Mountain Investor Presentation AECOM Investor Presentation World Trade Center Manhattan, New York, U.S.A. Safe Harbor Disclosures Cautionary Note Regarding Forward-Looking Statements All statements
More informationZimmer Biomet Holdings, Inc. 3rd Quarter 2017 Earnings Call Presentation. November 1, 2017
Zimmer Biomet Holdings, Inc. 3rd Quarter 2017 Earnings Call Presentation November 1, 2017 Cautionary Note on Forward-Looking Statements and Non- GAAP Financial Measures Our discussions during this presentation
More informationLHC GROUP AND ALMOST FAMILY ANNOUNCE MERGER OF EQUALS TO CREATE LEADING NATIONAL PROVIDER OF IN-HOME HEALTHCARE SERVICES
LHC GROUP AND ALMOST FAMILY ANNOUNCE MERGER OF EQUALS TO CREATE LEADING NATIONAL PROVIDER OF IN-HOME HEALTHCARE SERVICES National platform enables greater service and continuity across continuum of care
More informationInvestor Q&A. Q: When will the acquisition be completed?
Q: When will the acquisition be completed? Investor Q&A A: The acquisition is expected to be completed in the second quarter of 2017, subject to the satisfaction of certain customary conditions. The following
More informationNuVasive, Inc. 34 th Annual J.P. Morgan Healthcare Conference
NuVasive, Inc. 34 th Annual J.P. Morgan Healthcare Conference January 12, 2016 Greg Lucier Chairman and Chief Executive Officer Safe Harbor Statements Forward-looking information and non-gaap measures
More informationJohnson & Johnson publishes prospectus for Actelion tender offer
Page 1 of 6 Media Release 16 February 2017 Johnson & Johnson publishes prospectus for Actelion tender offer ALLSCHWIL/BASEL, SWITZERLAND 16 February 2017 Actelion Ltd (SIX: ATLN) today announced that Janssen
More informationHENRY SCHEIN TO SPIN OFF AND MERGE ITS ANIMAL HEALTH BUSINESS WITH VETS FIRST CHOICE, CREATING AN INNOVATIVE APPROACH TO ADVANCING VETERINARY CARE
HENRY SCHEIN TO SPIN OFF AND MERGE ITS ANIMAL HEALTH BUSINESS WITH VETS FIRST CHOICE, CREATING AN INNOVATIVE APPROACH TO ADVANCING VETERINARY CARE APRIL 23, 2018 Safe Harbor Statement Forward Looking Statements
More informationBrad Bishop Marc Ostermann Sam Leno
Contacts: Media Investors Brad Bishop Marc Ostermann Sam Leno 574-372-4291 574-371-8515 574-372-4790 bradley.bishop@zimmer.com marc.ostermann@zimmer.com sam.leno@zimmer.com Zimmer Reports Fourth Quarter
More informationBIOMET ANNOUNCES FIRST QUARTER OF FISCAL YEAR 2011 FINANCIAL RESULTS
BIOMET ANNOUNCES FIRST QUARTER OF FISCAL YEAR 2011 FINANCIAL RESULTS WARSAW, Ind., October 12, 2010 announced today financial results for its first fiscal quarter ended August 31, 2010. Net sales increased
More informationAllergan Reports Fourth Quarter 2014 Operating Results
Allergan Reports Fourth Quarter 2014 Operating Results IRVINE, Calif.--(BUSINESS WIRE)-- Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended December 31, 2014.Allergan also
More informationInvestor Presentation
Investor Presentation J.P. Morgan 36 th Annual Healthcare Conference San Francisco, CA January 2018 Forward-Looking Statements This presentation contains forward-looking statements (as defined in the Securities
More informationSafe Harbor Statement
April 12, 2018 Safe Harbor Statement Cautionary Statement Regarding Forward Looking Statements Statements in this presentation that are not historical, are forward-looking statements made pursuant to the
More informationQ1 FY19 Conference Call. November 1, 2018
Q1 FY19 Conference Call November 1, 2018 Forward Looking Statements and Financial Presentation This presentation contains forward-looking statements within the meaning of Section 27A of the Securities
More informationCIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE
CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE March 2018 Important Information for Investors and Shareholders FORWARD LOOKING STATEMENTS
More informationSafe Harbor Statement
June 27, 2018 Safe Harbor Statement Cautionary Statement Regarding Forward Looking Statements Statements in this presentation that are not historical, are forward-looking statements made pursuant to the
More informationBIOMET ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2011 PRELIMINARY FINANCIAL RESULTS
BIOMET ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2011 PRELIMINARY FINANCIAL RESULTS WARSAW, Ind., July 12, 2011 announced today preliminary financial results for its fourth quarter and fiscal year ended
More informationSmith & Nephew 2015 Third Quarter Trading Report Smith & Nephew delivers 4% underlying revenue growth; maintains full year guidance
Smith & Nephew Third Quarter Trading Report Smith & Nephew delivers 4 underlying revenue ; maintains full year guidance 29 October Smith & Nephew plc (LSE:SN, NYSE:SNN) trading report for the third quarter
More informationImportant Information for Investors and Stockholders
March 1, 2010 Important Information for Investors and Stockholders This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any
More informationQuad/Graphics, Inc. Call to Review Definitive Agreement to Acquire LSC Communications, Inc. and 3 rd Quarter 2018 Results.
Quad/Graphics, Inc. Call to Review Definitive Agreement to Acquire LSC Communications, Inc. and 3 rd Quarter 2018 Results October 31, 2018 Call Participants Joel Quadracci Chairman, President & Chief Executive
More informationINVITAE: Genetics from downstream to mainstream Q CONFERENCE CALL
INVITAE: Genetics from downstream to mainstream Q2 2017 CONFERENCE CALL Safe harbor statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationEmerson + Rockwell Automation: A Compelling Value Creation Opportunity for Shareholders. November 16, 2017
Emerson + Rockwell Automation: A Compelling Value Creation Opportunity for Shareholders November 16, 2017 1 Important Information for Investors and Stockholders This presentation relates to a proposal
More informationAEP INDUSTRIES INC. REPORTS FISCAL 2016 RESULTS
FOR IMMEDIATE RELEASE Contact: Paul M. Feeney Executive Vice President, Finance and Chief Financial Officer AEP Industries Inc. (201) 807-2330 feeneyp@aepinc.com AEP INDUSTRIES INC. REPORTS FISCAL 2016
More informationGartner to Acquire CEB for $2.6 Billion in Cash and Stock
Gartner to Acquire CEB for $2.6 Billion in Cash and Stock Creates the Leading Global Research and Advisory Company for All Major Functions in the Enterprise Gartner s Proven Operational Expertise and Sustained
More informationQ3 FY18 Conference Call. May 2, 2018
Q3 FY18 Conference Call May 2, 2018 Forward Looking Statement and Financial Presentation This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of
More informationFourth Quarter and Full Year 2017 Results. March 1, 2018
1 Fourth Quarter and Full Year 2017 Results March 1, 2018 Impax Cautionary Statement Regarding Forward Looking Statements 2 "Safe Harbor" statement under the Private Securities Litigation Reform Act of
More informationEntegris and Versum Materials Merger of Equals
Entegris and Versum Materials Merger of Equals Creation of a Premier Specialty Materials Company January 28, 2019 Forward-Looking Statements This communication contains forward-looking statements within
More informationMarvell and Cavium to Combine Creating an Infrastructure Solutions Powerhouse NOVEMBER 20, 2017
Marvell and Cavium to Combine Creating an Infrastructure Solutions Powerhouse NOVEMBER 20, 2017 Cautionary Statement Regarding Forward Looking Statements This document contains certain forward-looking
More informationFiled by Rockwell Collins, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6 under the Securities
Filed by Rockwell Collins, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934 Filer: Rockwell Collins, Inc. Subject
More informationGRANITE CONSTRUCTION TO ACQUIRE LAYNE CHRISTENSEN
GRANITE CONSTRUCTION TO ACQUIRE LAYNE CHRISTENSEN A PLATFORM FOR GROWTH FEBRUARY 2018 Safe Harbor Forward Looking Statements All statements included or incorporated by reference in this communication,
More informationExactech sustains a customer centric culture that creates customer loyalty
Exactech sustains a customer centric culture that creates customer loyalty Targeting $30 billion global biomedical device market Consistent long term growth 2x as fast as overall market Broad product portfolio
More informationThis FAQ was made available on January 16, 2019 to certain members of Fiserv, Inc. s management and investor relations department.
Filed by Fiserv, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: First Data Corporation Commission
More informationStryker. Kevin A. Lobo Chairman and Chief Executive Officer
Stryker Kevin A. Lobo Chairman and Chief Executive Officer Disclaimer Forward-looking statement This presentation contains information that includes or is based on forward-looking statements within the
More informationStryker. Kevin A. Lobo Chairman and Chief Executive Officer
Stryker Kevin A. Lobo Chairman and Chief Executive Officer Disclaimer Forward-looking statement This presentation contains information that includes or is based on forward looking statements within the
More informationSTRYKER. Kevin A. Lobo, President & Chief Executive Officer
STRYKER Kevin A. Lobo, President & Chief Executive Officer January 15, 2014 FORWARD LOOKING STATEMENT Certain statements made in the presentation may contain information that includes or is based on forward-looking
More informationHewlett Packard Enterprise Announces Plans for Tax-Free Spin-Off and Merger of Enterprise Services Business with CSC
Hewlett Packard Enterprise Announces Plans for Tax-Free Spin-Off and Merger of Enterprise Services Business with CSC Investor Presentation May 24, 2016 Forward Looking Statements Information set forth
More informationAcquisition of Astra Tech June 22, 2011 NASDAQ-XRAY
Acquisition of Astra Tech June 22, 2011 1 Forward Looking Statements This presentation, in addition to historical information, contains forward-looking statements (as defined in the Securities Litigation
More informationOrthofix International Announces 45% Revenue Growth In Third Quarter 2007 Results
Orthofix International Announces 45% Revenue Growth In Third Quarter 2007 Results HUNTERSVILLE, N.C.--(BUSINESS WIRE)--Nov. 6, 2007--Orthofix International N.V., (NASDAQ:OFIX): Third quarter sales totaled
More informationMeta Financial Group, Inc. Transformational Merger with Crestmark Bancorp, Inc. Investor Presentation January 9, 2018
Meta Financial Group, Inc. Transformational Merger with Crestmark Bancorp, Inc. Investor Presentation January 9, 2018 Forward-Looking Statements Meta Financial Group, Inc. (the Company or Meta ) and its
More informationRaymond James Institutional Investor Conference
Raymond James Institutional Investor Conference Bob Dellinger Executive Vice President & CFO Cautionary Statement Regarding Forward-Looking Information The information highlighted in this presentation
More informationSYNNEX Concentrix Division Announces the Acquisition of Convergys
Filed by SYNNEX Corporation pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company:
More information2008 Third Quarter Results. Sustainable profitable growth
2008 Third Quarter Results Sustainable profitable growth 0 Forward looking statements This presentation contains certain "forwardlooking statements" within the meaning of the US Private Securities Litigation
More informationDENTSPLY and Sirona Announce Combination to Create The Dental Solutions Company in $13 Billion Merger of Equals
FOR IMMEDIATE RELEASE DENTSPLY and Sirona Announce Combination to Create The Dental Solutions Company in $13 Billion Merger of Equals Combination of Leading Platforms in Consumables, Equipment and Technology
More informationOCTOBER 2016 ACQUISITION OF MERCHANTS BANCSHARES, INC.
OCTOBER 2016 ACQUISITION OF MERCHANTS BANCSHARES, INC. Forward-Looking Statement & Additional Information This presentation contains certain forward-looking statements within the meaning of the Private
More informationCompelling Strategic Transaction
ACQUISITION OF DJO GLOBAL November 19, 2018 Forward Looking Statements & Non-GAAP Disclaimer The following information may contain forward-looking statements, including forward-looking statements within
More informationOssur First Quarter Report 2008
Ossur First Quarter Report Press release from Ossur hf. Reykjavik, 29 April First Quarter Highlights Sales USD 89.8 million Organic growth 12% EBITDA USD 23 million, up by 124% from EBITDA adjusted USD
More informationTivity Health + Nutrisystem Expanding our Healthy Lifestyle Brand Portfolio Tivity Health, Inc. All rights reserved.
Tivity Health + Nutrisystem Expanding our Healthy Lifestyle Brand Portfolio 1 2018 Tivity Health, Inc. All rights reserved. Cautionary Note on Forward-Looking Statements Note On Forward Looking Statements
More informationGALENA BIOPHARMA, INC.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event
More informationBJ SERVICES CO Filed by BAKER HUGHES INC
BJ SERVICES CO Filed by BAKER HUGHES INC FORM 425 (Filing of certain prospectuses and communications in connection with business combination transactions) Filed 01/12/10 Address 4601 WESTWAY PARK BLVD
More informationLHC Group and Almost Family: A Leading National Provider of In-Home Healthcare. November 16, 2017
LHC Group and Almost Family: A Leading National Provider of In-Home Healthcare November 16, 2017 Forward-Looking Statements This presentation contains forward looking statements (as defined in the Securities
More informationAssurant and The Warranty Group: Creating a Leading Global Lifestyle Provider
Assurant and The Warranty Group: Creating a Leading Global Lifestyle Provider 1 Safe Harbor Statement Some of the statements included in this presentation, particularly those with respect to the proposed
More informationNUVASIVE REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS
NEWS RELEASE NUVASIVE REPORTS SECOND QUARTER 07 FINANCIAL RESULTS SAN DIEGO, CA July 7, 07 NuVasive, Inc. (Nasdaq: NUVA), a leading medical device company focused on transforming spine surgery with minimally
More informationMicrel Acquisition May 7, 2015
Micrel Acquisition May 7, 2015 Filed by Microchip Technology Incorporated pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act
More informationOrthofix International Announces Second Quarter 2007 Sales Growth of 46%
Orthofix International Announces Second Quarter 2007 Sales Growth of 46% HUNTERSVILLE, N.C.--(BUSINESS WIRE)--Aug. 7, 2007--Orthofix International N.V., (NASDAQ: OFIX): Second quarter sales totaled $123.3
More informationJohnson & Johnson Reports Fourth-Quarter and Full-Year 2007 Results
Johnson & Johnson Reports Fourth-Quarter and Full-Year 2007 Results 2007 Fourth-Quarter Sales of $16.0 Billion increased 16.6%; EPS of $.82 2007 Full-Year Sales of $61.1 Billion increased 14.6%; Full-Year
More informationESSENDANT AND GENUINE PARTS COMPANY S S.P. RICHARDS BUSINESS TO COMBINE TO FORM STRONGER, MORE COMPETITIVE NATIONAL BUSINESS PRODUCTS DISTRIBUTOR
ESSENDANT AND GENUINE PARTS COMPANY S S.P. RICHARDS BUSINESS TO COMBINE TO FORM STRONGER, MORE COMPETITIVE NATIONAL BUSINESS PRODUCTS DISTRIBUTOR Creates Combined Company with Enhanced Ability to Serve
More informationJefferies 2014 Global Healthcare Conference. June 4, 2014
Jefferies 2014 Global Healthcare Conference June 4, 2014 1 Forward-Looking Statements This presentation may contain forward-looking statements as defined under U.S. federal securities laws, including statements
More informationPress Information. June 28, 2017
Press Information June 28, 2017 Philips to acquire The Spectranetics Corporation to accelerate expansion in imageguided therapy devices to treat cardiac and peripheral vascular disease Highly complementary
More informationInvestor Presentation June 18, 2014 TE CONNECTIVITY ACQUIRES MEASUREMENT SPECIALTIES
Investor Presentation June 18, 2014 TE CONNECTIVITY ACQUIRES MEASUREMENT SPECIALTIES Forward-Looking Statements Forward Looking Statements This presentation contains certain forward-looking statements
More informationMay Acquisition of AEP Industries Inc. August 2016
May 2015 Acquisition of AEP Industries Inc. August 2016 Safe Harbor Statements Forward-Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the
More informationNASDAQ : SSYS. April Stratasys, Inc. and Objet Ltd. Combining to Create a Leader in 3D Printing. Building for Future Growth
April 2012 Stratasys, Inc. and Objet Ltd. Combining to Create a Leader in 3D Printing Building for Future Growth Safe harbor statement Statements in this presentation about Stratasys beliefs, intentions
More informationLinde plc Announces Satisfaction of Final Conditions to Close Business Combination between Linde AG and Praxair
Linde plc Announces Satisfaction of Final Conditions to Close Business Combination between Linde AG and Praxair Creates leading industrial gas company, with a market capitalization of approximately USD
More informationXylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016
1 Xylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016 Forward-Looking Statements This presentation contains information that may constitute forward-looking statements.
More informationAIG Acquisition of Validus Holdings: A Step Forward in AIG s Profitable Growth Strategy. Investor Presentation January 22, 2018
AIG Acquisition of Validus Holdings: A Step Forward in AIG s Profitable Growth Strategy Investor Presentation January 22, 2018 Disclaimer Forward-Looking Statements Certain statements in this presentation
More informationAmcor & Bemis Combination Creating the Global Leader in Consumer Packaging. 6 August 2018
Amcor & Bemis Combination Creating the Global Leader in Consumer Packaging 6 August 2018 Disclaimer Cautionary Statement Regarding Forward-Looking Statements This communication contains certain statements
More informationSubject Company: Connecticut Water Service, Inc. (Commission File No )
Filed by Eversource Energy (Commission File No. 001-05324) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject
More informationSmith & Nephew First Quarter 2018 Trading Report
Smith & Nephew First Quarter 2018 Trading Report 3 May 2018 Smith & Nephew plc (LSE:SN, NYSE:SNN) trading report for the first quarter ended 31 March 2018. Highlights 1,2 First quarter revenue $1,196 million
More informationQ Earnings Call
We make healthy possible Q3 2018 Earnings Call Financial Results and Business Update November 7, 2018 Safe Harbor Statement & Non-GAAP Financial Measures Safe Harbor Statement Certain statements contained
More informationThe Right Alternative: A Focus on Growth and Innovation
Filed by IntercontinentalExchange, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended
More informationFiled by T-Mobile US, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities
Filed by T-Mobile US, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Sprint Corporation Commission
More informationUnivar Inc. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationMarriott Vacations Worldwide to Acquire ILG to Create a Leading Global Provider of Premier Vacation Experiences
Marriott Vacations Worldwide to Acquire ILG to Create a Leading Global Provider of Premier Vacation Experiences Leading upper-upscale and luxury vacation ownership and exchange company will have over 00
More informationJefferies 2016 Healthcare Conference CEO. June 7, 2016 NYSE: Q. Copyright 2016 Quintiles
Jefferies 2016 Healthcare Conference Tom Pike CEO June 7, 2016 Copyright 2016 Quintiles NYSE: Q Cautionary Statements Regarding Forward Looking Statements This communication contains forward-looking statements
More informationExactech sustains a customer centric culture that creates customer loyalty
Experience Exactech. Investor Presentation Key to Our Success Exactech sustains a customer centric culture that creates customer loyalty Investment Highlights Targeting $41 billion global biomedical device
More informationDETREX CORPORATION - (OTCQX:DTRX) November 14, Merger Agreement for the Sale of Detrex to Italmatch for $27 per share in Cash Announced
PRESS RELEASE DETREX CORPORATION - (OTCQX:DTRX) November 14, 2017 Contact: Thomas E. Mark Phone: (216) 749-2605 ext. 113 Merger Agreement for the Sale of Detrex to Italmatch for $27 per share in Cash Announced
More informationMICT Reports Second Quarter 2018 Financial Results
MICT Reports Second Quarter 2018 Financial Results - Completes sale of Enertec Systems for total effective transaction price of $8.7 million - A net profit of $3.5 million for the three months ended June
More informationSJW GROUP AND CONNECTICUT WATER SERVICE, INC. TO COMBINE IN ALL-STOCK TRANSACTION TO CREATE LEADING WATER UTILITY COMPANY
SJW GROUP AND CONNECTICUT WATER SERVICE, INC. TO COMBINE IN ALL-STOCK TRANSACTION TO CREATE LEADING WATER UTILITY COMPANY Combined Company to be 3 rd Largest Investor-Owned Water and Wastewater Utility
More informationWashington Federal Announces Quarterly Earnings Per Share Of $0.57
Exhibit 99.1 Wednesday, April 11, 2018 FOR IMMEDIATE RELEASE Washington Federal Announces Quarterly Earnings Per Share Of $0.57 SEATTLE, WASHINGTON Washington Federal, Inc. (Nasdaq: WAFD) (the "Company"),
More informationA Winning Combination: Creating a Consumer Goods Powerhouse
A Winning Combination: Creating a Consumer Goods Powerhouse December 14, 2015 Forward-Looking Statements Statements in this presentation that are not historical in nature constitute forward looking statements.
More informationNASDAQ: HSIC Q3 2018
NASDAQ: HSIC Q3 2018 Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information Safe Harbor Provision Forward Looking Statements In accordance with the "Safe Harbor"
More informationForward-Looking Statements
February 20, 2007 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but
More informationJPMorgan Healthcare Conference January 2009 Helping people regain their right to an active lifestyle
JPMorgan Healthcare Conference January 2009 Helping people regain their right to an active lifestyle 0 Forward looking statements This presentation contains certain "forward-looking statements" within
More informationAccelerating Category Leadership. May 1, 2017
Accelerating Category Leadership May 1, 2017 1 Cautionary Statement Regarding Forward-Looking Information The information presented herein may contain forward-looking statements within the meaning of the
More informationDisclaimer / Forward Looking Statements
Disclaimer / Forward Looking Statements Statements in this presentation regarding Symmetry Medical Inc. s business, which are not historical facts, may be forward-looking statements that involve risks
More informationBe Secure. Be Positive. Rodman & Renshaw Annual Global Investment Conference
P sitiveid Be Secure. Be Positive Rodman & Renshaw Annual Global Investment Conference Safe Harbor Statement Information contained in this presentation may contain forward-looking statements, including,
More informationPRAXAIR NEWS RELEASE. Praxair Reports Third-Quarter 2017 Results
PRAXAIR NEWS RELEASE Praxair Reports Third-Quarter 2017 Results Media Contact: Lisa Esneault (203) 837-2448 lisa_esneault@praxair.com Investor Contact: Juan Pelaez (203) 837-2213 juan_pelaez@praxair.com
More informationNASDAQ: HSIC Q1 2018
NASDAQ: HSIC Q1 2018 Cautionary Note Regarding Forward-Looking Statements and Use of Non-GAAP Financial Information Safe Harbor Provision Forward Looking Statements In accordance with the "Safe Harbor"
More informationCIGNA GLOBAL SUPPLEMENTAL BENEFITS
CIGNA GLOBAL SUPPLEMENTAL BENEFITS As of February, 2016 1 Forward looking statements and non-gaap measures CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION
More information2010 Full Year Results strong finish to the year
2010 Full Year Results strong finish to the year 1 Forward looking statements This document contains certain forward-looking statements that may or may not prove accurate. For example, statements regarding
More informationKeyBanc Capital Markets Industrial, Automotive and Transportation Conference
KeyBanc Capital Markets Industrial, Automotive and Transportation Conference Richard Fearon Vice Chairman and Chief Financial and Planning Officer May 30, 2012 The directors of Eaton Corporation accept
More informationWalgreens-Alliance Boots Investor Call
Walgreens-Alliance Boots Investor Call August 6, 2014 Investor Call Agenda Introduction & Safe Harbor Alliance Boots Step 2 Update Global Management Structure Corporate Structure Rick Hans, CFA Divisional
More information